🇨🇿 Czech Republic Country × Condition
neovascular age related macular degeneration Clinical Trials in Czech Republic
Active clinical trials for neovascular age related macular degeneration with research sites in Czech Republic. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇨🇿 Czech Republic
Active Trials in Czech Republic (2)
NCT06847542 Phase 3
Recruiting
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Enrollment
250 pts
Country
🇨🇿 Czech Republic
Hoffmann-La Roche
View Trial → NCT06680817
Recruiting
A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)
Enrollment
850 pts
Country
🇨🇿 Czech Republic
Hoffmann-La Roche
View Trial → Frequently Asked Questions
How many neovascular age related macular degeneration clinical trials are active in Czech Republic?
There are currently 2 active clinical trials for neovascular age related macular degeneration with sites in Czech Republic, of which 2 are actively recruiting patients.
How can I join a neovascular age related macular degeneration clinical trial in Czech Republic?
To join a neovascular age related macular degeneration clinical trial in Czech Republic, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Czech Republic directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are neovascular age related macular degeneration trials in Czech Republic?
Active neovascular age related macular degeneration trials in Czech Republic span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.